Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.5.3 to v3.5.4, indicating a software update to the site's interface.
    Difference
    0.0%
    Check dated 2026-05-18T13:25:46.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.0 to v3.5.3, reflecting a change in the site/version display rather than any study information.
    Difference
    0.0%
    Check dated 2026-04-27T07:32:06.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study results section now includes posted results data (ORR by RECIST v1.1 with 18-month follow-up) and related dates/documents, and Cohort 3 has been renamed from 'Safety and Tolerability' to 'Tolerability' with a 100-day dosing assessment.
    Difference
    2%
    Check dated 2026-04-05T16:47:43.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Results Submitted is now displayed and the page revision updated to v3.5.0, replacing the previous No Results Posted and revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-22T05:48:28.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated: from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T18:52:34.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Added Fallopian tube cancer to the listed conditions and introduced the Genetic and Rare Diseases Information Center as a resource; updated page revision from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-14T12:32:44.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.